Search

Why cell and gene therapy manufacturing has a lot to learn from the automotive sector.

Counterfeit medicines pose a significant threat to global health. A recent study uncovers alarming facts and emphasizes the need for solutions.

Delali Attipoe at the DNDi explains why we need an R&D model attuned to the needs of forgotten patients.

The public’s perception of the industry is low. How can we fix it?

Experts discuss the trends, challenges, and possibilities of cryopreservation for cell and gene – and how it can freeze time in manufacturing.

Research and development in sleep-wake disorders has been asleep on its feet

Looking for words of wisdom and tips on being a leader and advancing your career in pharma?

Sitting Down With … Piper Trelstad, Head of CMC, The Bill & Melinda Gates Medical Research Institute

As part of our 10-year anniversary special feature, Markus Kosch tells us his views on the future of pharma.

What does the future hold for pharma? Audrey Greenberg and Jon Zwinski give their views.